Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE37.5700
- TODAY'S CHANGE (%)-1.4200 (-3.6420%)
- Bid / Lots37.5000/ 4
- Ask / Lots37.6100/ 1
- Open / Previous Close38.7100 / 38.9900
- Day Range
- 52 Week Range
- Volume385,821
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 3355 | 39 |
| 09:34 ET | 1100 | 38.88 |
| 09:36 ET | 781 | 39.32 |
| 09:39 ET | 1897 | 39.35 |
| 09:43 ET | 945 | 39.29 |
| 09:45 ET | 209 | 39.18 |
| 09:48 ET | 11789 | 39.285 |
| 09:50 ET | 700 | 39.23 |
| 09:52 ET | 2885 | 39.33 |
| 09:54 ET | 1682 | 39.23 |
| 09:56 ET | 1332 | 39.22 |
| 09:57 ET | 1800 | 38.97 |
| 09:59 ET | 1398 | 39 |
| 10:01 ET | 1100 | 39 |
| 10:03 ET | 1700 | 38.79 |
| 10:06 ET | 3508 | 38.7 |
| 10:08 ET | 1600 | 38.48 |
| 10:10 ET | 1850 | 38.505 |
| 10:12 ET | 2500 | 38.33 |
| 10:14 ET | 1300 | 38.44 |
| 10:15 ET | 700 | 38.34 |
| 10:17 ET | 3999 | 38.24 |
| 10:19 ET | 1800 | 38.305 |
| 10:21 ET | 5970 | 38.475 |
| 10:24 ET | 1200 | 38.36 |
| 10:26 ET | 2700 | 38.35 |
| 10:28 ET | 1097 | 38.523 |
| 10:30 ET | 2636 | 38.445 |
| 10:32 ET | 2555 | 38.35 |
| 10:33 ET | 1759 | 38.29 |
| 10:35 ET | 7799 | 38.3 |
| 10:37 ET | 1600 | 38.12 |
| 10:39 ET | 1700 | 38.01 |
| 10:42 ET | 1200 | 38.185 |
| 10:44 ET | 1392 | 38.3 |
| 10:46 ET | 25711 | 38.285 |
| 10:48 ET | 500 | 38.22 |
| 10:50 ET | 700 | 38 |
| 10:51 ET | 771 | 38.065 |
| 10:53 ET | 1324 | 38.22 |
| 10:55 ET | 266 | 38.12 |
| 10:57 ET | 255 | 38.06 |
| 11:00 ET | 324 | 38.005 |
| 11:02 ET | 287 | 37.995 |
| 11:04 ET | 600 | 38.025 |
| 11:06 ET | 1400 | 37.95 |
| 11:08 ET | 800 | 37.9 |
| 11:09 ET | 1160 | 38.03 |
| 11:11 ET | 2145 | 37.85 |
| 11:15 ET | 727 | 37.7 |
| 11:18 ET | 2200 | 37.795 |
| 11:20 ET | 1900 | 37.87 |
| 11:22 ET | 805 | 37.95 |
| 11:24 ET | 200 | 37.89 |
| 11:27 ET | 300 | 37.93 |
| 11:29 ET | 1000 | 37.97 |
| 11:31 ET | 1800 | 37.98 |
| 11:33 ET | 396 | 37.915 |
| 11:36 ET | 200 | 37.91 |
| 11:38 ET | 200 | 37.905 |
| 11:42 ET | 600 | 37.86 |
| 11:44 ET | 1960 | 37.895 |
| 11:47 ET | 665 | 37.96 |
| 11:49 ET | 700 | 37.94 |
| 11:51 ET | 600 | 37.98 |
| 11:54 ET | 700 | 37.96 |
| 11:56 ET | 733 | 37.9617 |
| 11:58 ET | 1095 | 37.98 |
| 12:00 ET | 500 | 38.03 |
| 12:03 ET | 200 | 37.94 |
| 12:05 ET | 300 | 37.94 |
| 12:07 ET | 400 | 37.955 |
| 12:12 ET | 300 | 37.955 |
| 12:14 ET | 1600 | 37.97 |
| 12:16 ET | 300 | 37.96 |
| 12:18 ET | 5124 | 37.9 |
| 12:20 ET | 1000 | 37.955 |
| 12:21 ET | 700 | 37.87 |
| 12:23 ET | 112315 | 37.76 |
| 12:25 ET | 200 | 37.6 |
| 12:27 ET | 2300 | 37.76 |
| 12:30 ET | 500 | 37.7 |
| 12:32 ET | 500 | 37.685 |
| 12:34 ET | 400 | 37.685 |
| 12:36 ET | 400 | 37.685 |
| 12:38 ET | 2200 | 37.66 |
| 12:39 ET | 200 | 37.69 |
| 12:43 ET | 1000 | 37.615 |
| 12:45 ET | 1600 | 37.61 |
| 12:48 ET | 100 | 37.61 |
| 12:52 ET | 500 | 37.66 |
| 12:56 ET | 976 | 37.81 |
| 12:59 ET | 358 | 37.805 |
| 01:01 ET | 208 | 37.6701 |
| 01:03 ET | 1094 | 37.67 |
| 01:06 ET | 100 | 37.75 |
| 01:12 ET | 100 | 37.78 |
| 01:14 ET | 800 | 37.8 |
| 01:15 ET | 100 | 37.86 |
| 01:17 ET | 300 | 37.79 |
| 01:24 ET | 300 | 37.83 |
| 01:26 ET | 812 | 38.07 |
| 01:32 ET | 1592 | 37.965 |
| 01:33 ET | 100 | 37.955 |
| 01:35 ET | 100 | 37.95 |
| 01:37 ET | 2300 | 37.88 |
| 01:39 ET | 52252 | 37.77 |
| 01:42 ET | 26281 | 37.685 |
| 01:44 ET | 1058 | 37.5 |
| 01:46 ET | 700 | 37.47 |
| 01:48 ET | 400 | 37.57 |
Jun 18, 2024
DJ Xenon Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital, from 8:59AM ET on Tuesday Jun 18, 2024 by Dow Jones
8:59AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 5, 2024
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 2.9B | -13.9x | --- |
Biohaven Ltd | 3.1B | -5.1x | --- |
MoonLake Immunotherapeutics | 2.8B | -55.9x | --- |
SpringWorks Therapeutics Inc | 2.8B | -7.5x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Geron Corp | 2.5B | -12.5x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -13.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
